The Effect of Lipoprotein (a) on Arterial Stiffness, Endothelial Function and Myocardial Deformation

Recruiting Observational Study
Lipoprotein Disorder Arterial Stiffness Endothelial Dysfunction
No Placebo Group Every participant receives an active treatment — no one gets a placebo. Healthy Volunteers Welcome You do not need to have the condition being studied to take part. No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 – 75
Sex
Any
Study type
Observational
Participants needed
300 (estimated)
Sponsor
University of Athens · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
1. Introduction Lipoprotein(a), or Lp(a), is a type of lipoprotein that is structurally similar to LDL (low-density lipoprotein) but carries an additional protein called apolipoprotein (a). 2. Purpose of the Study The primary purpose of this study is to investigate the effect of Lp(a) levels on arterial stiffness, endothelial function, and left atrial (LA) and left ventricular (LV) deformation…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Adults participants 18-75 years old * Willing to sign the informed consent and paerticipate in the study Exclusion Criteria: * History of autoimmune/autoinflammatory disease, * Severe valvular heart disease, * severe chronic kidney disease(eGFR\<60 ml/min/1.73 m2), * Active …
Contacts

Ignatios Ikonomidis

+30 694 4805732

ignoik@gmail.com

CONTACT